Skip to main content

Day: June 29, 2020

North American Leader In Healthcare Management Chronometriq Acquires Fellow Canadian Health Myself

MONTREAL, June 29, 2020 (GLOBE NEWSWIRE) — Montreal-based Chronometriq announces today the acquisition of healthcare management competitor Health Myself.Founded in 2013, Health Myself specializes in enabling primary care teams to dispense higher quality care at a lower cost. Their strong portfolio of patient engagement technologies, namely solutions for virtual care, mass communications and a patient portal, supports Chronometriq’s pursuit of growth opportunities and complements its product platform.Chronometriq will fully integrate with Health Myself, maintaining relationships and contracts with current clients as well as preserving and leveraging their team and technology into an enhanced suite of products, offering the most complete solution for clinics in Canada and accelerating its expansion into the US market.Yan Raymond-Lalande,...

Continue reading

Le Leader Nord-américain En Gestion Des Soins De Santé Chronometriq Acquiert L’entreprise Canadienne Health Myself

MONTRÉAL, 29 juin 2020 (GLOBE NEWSWIRE) — La société montréalaise Chronometriq annonce aujourd’hui l’acquisition de Health Myself, une entreprise concurrente dans l’industrie de la gestion des soins de santé.Fondée en 2013, Health Myself est spécialisée pour permettre aux équipes de soins primaires d’offrir des soins de meilleure qualité à moindre coût. Son éventail important de technologies d’engagement avec les patients, notamment des solutions de soins virtuels, de communication de masse et un portail pour les patients, soutient la poursuite des opportunités de croissance de Chronometriq et complète sa plateforme de produits.Chronometriq s’intégrera complètement à Health Myself, en maintenant les relations et les contrats avec les clients actuels ainsi qu’en préservant et en bénéficiant de son équipe et de sa technologie dans...

Continue reading

Notice of second quarter 2020 results and conference call 

Notice of second quarter 2020 results and conference call Luxembourg, June 29, 2020 – Millicom will announce its second-quarter results on July 30, 2020 at approximately 12:00 (Stockholm) / 11:00 (London) / 06:00 (Miami) via a press release.The company will host a conference call for the global financial community on July 30, 2020 at 15:00 (Stockholm) / 14:00 (London) / 09:00 (Miami).The conference call will be webcast at millicom.comDial-in information:Please dial in 5-10 minutes before the scheduled start time to register your attendance. Dial-in numbers for the call are as follows:Sweden:          +46-(0)-8566-18467                            Luxembourg:  +352-2786-0549UK:                  +44-(0)-8444-819752                          US:                   +1-646-741-3167The access code is: 8857678Replay information:A replay of the...

Continue reading

Email Marketing Software Market to Reach USD 2,275.5 Million by 2027; Rising Attractiveness towards Promotional Emails to Aid Expansion, states Fortune Business Insights™

Pune, June 29, 2020 (GLOBE NEWSWIRE) — The global email marketing software market size is predicted to reach USD 2,275.5 million by 2027, exhibiting a CAGR of 10.5% during the forecast period. The increasing attention by companies towards promotional emails to attract customers will be a dynamic factor for the growth of the market during the forecast period, states Fortune Business Insights in a report, titled “Email Marketing Software Market Size, Share and Industry Analysis, By Channel (Business-to-Business (B2B) and Business-to-Customers (B2C)), Deployment (On-Premise and Cloud), By Enterprise Size (Large Enterprises, Small & Medium Enterprises), By Application (Email Lead Generation, Sales Reporting, Customer Management, Template Management, Reporting and Analytics, and Others), By Industry (Banking, Finance, Security and...

Continue reading

Saga Furs Oyj:n puolivuosikatsaus 1.11.2019–30.4.2020

 Saga Furs Oyj puolivuosikatsaus 29.6.2020 klo 16.45 Koronaviruspandemia vaikeutti huutokauppatoimintaa, liikevaihto ja tulos heikkenivät merkittävästi.Tämä on tiivistelmä Saga Furs Oyj:n julkaisemasta puolivuosikatsauksesta. Kokonaisuudessaan katsaus on tämän tiedotteen liitteenä ja yhtiön internetsivulla www.sagafurs.com.ENSIMMÄISEN PUOLIVUOSIKAUDEN KESKEISET ASIATSaga Furs Oyj:n välitysmyynnin arvo laski 30.4.2020 päättyneellä puolivuosikaudella 65 prosenttia. vertailukaudesta ja oli 45 miljoonaa euroa (vertailukaudella 127 milj. euroa).Yhtiö välitti puolivuosikauden aikana 1,6 miljoonaa nahkaa (3,3 milj. nahkaa).Välitetty minkkimäärä laski noin 40 prosenttia, välitetty kettumäärä noin 80 prosenttia.Konsernin välitysmyyntiä pienensi merkittävästi koronaviruspandemia, jonka vuoksi asetetut matkustus- ja kokoontumisrajoitukset estivät...

Continue reading

Saga Furs Oyj:s halvårsrapport för perioden 1.11.2019–30.4.2020

Saga Furs Oyj, halvårsrapport 29.6.2020 kl. 16.45Coronaviruspandemin försvårade auktionsverksamheten, omsättningen och resultatet försvagades betydligtCENTRALT UNDER DEN FÖRSTA HALVÅRSPERIODENUnder halvårsperioden som avslutades den 30.4.2020 minskade värdet på Saga Furs Oyj:s förmedlingsförsäljning med 65 procent jämfört med jämförelseperioden och var 45 miljoner euro (127 milj. euro under jämförelseperioden).Under halvårsperioden förmedlade bolaget 1,6 miljoner skinn (3,3 milj. skinn).Antalet förmedlade minkskinn sjönk ca 40 procent, antalet förmedlade rävskinn ca 80 procent.Koncernens förmedlingsförsäljning minskade betydligt på grund av coronaviruspandemin, då rese- och mötesrestriktionerna omöjliggjorde ordnandet av mars-aprilauktionen. Istället såldes skinnen för första gången via en nätauktion.Koncernens omsättning sjönk med 53...

Continue reading

Avalon GloboCare Announces Successful Completion of Phase I Clinical Study of CAR T-Cell Therapy Candidate AVA-001

– Completed Phase I Clinical Study of 4-1BB Based Anti-CD19 CAR-T Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia– Achieved 90% Complete Remission (CR) Rate with Minimum Toxicity or Adverse Side Effects; Successfully “Bridging” to Allogeneic Bone Marrow Transplant with Curative Intent– Results will be Presented on July 11, 2020 at The Eighth Annual Lu Daopei Hematology Forum, the largest Hematology Conference in AsiaFREEHOLD, N.J., June 29, 2020 (GLOBE NEWSWIRE) — Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, announced today it has successfully completed Phase I first-in-human clinical study of its leading Chimeric Antigen Receptor (CAR) T-cell therapy candidate, AVA-001 (National Institute of Health...

Continue reading

China Recycling Energy Corporation Reports Results for the First Quarter of 2020

XI’AN, China, June 29, 2020 (GLOBE NEWSWIRE) — China Recycling Energy Corporation (NASDAQ: CREG) (“CREG” or “the Company”), an industrial waste-to-energy solution provider in China, today reported certain highlights of its operating results for the quarter ended March 31, 2020.“As of March 31, 2020, we maintained a healthy cash and cash equivalents balance of approximately $55.0 million,” stated Mr. Guohua Ku, Chairman and CEO of the Company. In addition, we have accomplished significant cost cutting throughout our entire organization, evidenced by net loss narrowed by approximately 69.2% to approximately $(0.6) million in the first quarter ended March 31, 2020, as compared to approximately $(1.9) million in the same period of 2019. We are executing what we believe is a clear plan to manage our business...

Continue reading

Construction contract in Lithuania (NATO barracks in Kaunas)

On 29 June 2020, UAB Merko Statyba, part of AS Merko Ehitus group, and North Atlantic Treaty Organization (NATO) Support and Procurement Agency entered into a contract to perform reconstruction works of a historical building as barracks in Kaunas in Lithuania.  The contract value is approximately EUR 6 million, without value added tax. The construction works are scheduled to be completed in August 2021.  UAB Merko Statyba (merko.lt) is Lithuanian construction company, which offers construction services in the fields of general construction and residential construction.  Additional information: UAB Merko Statyba, Construction Director Mr. Jaanus Rästas, phone: +370 6875 0680.  Priit RoosimägiHead of Group Finance UnitAS Merko Ehitus+372 650 1250priit.roosimagi@merko.ee  AS Merko Ehitus (group.merko.ee) group consists of AS Merko Ehitus...

Continue reading

Ehitusleping Leedus (NATO kasarmud Kaunases)

ASi Merko Ehitus kontserni kuuluv UAB Merko Statyba ning Põhja-Atlandi Lepingu Organisatsiooni (NATO) toetus- ja hankeamet sõlmisid 29. juunil 2020 lepingu ajaloolise hoone rekonstrueerimiseks kasarmuks Kaunases Leedus.  Lepingu maksumus on ligikaudu 6 miljonit eurot (ilma käibemaksuta). Tööde valmimise tähtaeg on 2021. aasta augustis.   UAB Merko Statyba (merko.lt) on Leedu ehitusettevõte, mis teostab üld- ja elamuehituse töid.   Lisainfo: UAB Merko Statyba ehitusdirektor Jaanus Rästas, tel: +370 6875 0680.  Priit RoosimägiFinantsüksuse juhtAS Merko EhitusTelefon: +372 650 1250E-post: priit.roosimagi@merko.ee  AS Merko Ehitus (group.merko.ee) kontserni kuuluvad Eestis AS Merko Ehitus Eesti, Lätis SIA Merks, Leedus UAB Merko Statyba ning Norras Peritus Entreprenør AS. Peatöövõtjana ehitusteenuse osutamise kõrval on kontserni teiseks...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.